Effects of the Consumption of a Supplement Rich in Docosahexaenoic Acid (DHA) From Algae

NCT ID: NCT04278482

Last Updated: 2023-01-17

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Clinical Phase

NA

Total Enrollment

102 participants

Study Classification

INTERVENTIONAL

Study Start Date

2020-03-10

Study Completion Date

2021-07-05

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

Vegetarian diets are increasing worldwide. To prevent nutritional deficiencies, supplementation with nutrients that are only present in animal food can be needed. In relation to fatty acids, vegetarian diets involve low intake of omega-3 polyunsaturated fatty acids (n-3 PUFA) and low blood levels of the long-chain n-3 derivatives, whose main dietary sources are fish and shellfish, particularly the levels of docosahexaenoic acid (DHA), which has important health benefits, are low.

In this regard, validation of supplements rich in the n-3 fatty acid DHA that are not obtained from fish is needed, thus the study will test the bioavailability and metabolic effects of a DHA supplement form algae.

The study will be conducted on the effects of the DHA supplement versus placebo in vegetarian and non-vegetarian healthy adults.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Vegetarian Diet

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

CROSSOVER

Primary Study Purpose

OTHER

Blinding Strategy

QUADRUPLE

Participants Caregivers Investigators Outcome Assessors

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

DHA supplement

Supplement rich in DHA form algae source

Group Type ACTIVE_COMPARATOR

Dietary supplement, DHA or Placebo

Intervention Type DIETARY_SUPPLEMENT

Consumption of 2 capsules per day of the dietary supplement, DHA or Placebo

Placebo

Placebo supplement

Group Type PLACEBO_COMPARATOR

Dietary supplement, DHA or Placebo

Intervention Type DIETARY_SUPPLEMENT

Consumption of 2 capsules per day of the dietary supplement, DHA or Placebo

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Dietary supplement, DHA or Placebo

Consumption of 2 capsules per day of the dietary supplement, DHA or Placebo

Intervention Type DIETARY_SUPPLEMENT

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Adult (age ≥18 and ≤45 years).
* Healthy.
* Women.
* Men.
* Participant following either a vegetarian diet during at least 6 months or following a omnivorous diet but consuming fish 2 times per week or less.

Exclusion Criteria

* Age \<18 and \>45 years old.
* Pregnancy.
* Diseases: liver diseases, gastric diseases, irritable bowel, hypercholesterolemia, hypertension, diabetes, biliary colic.
* Having participated in a clinical study in the last 3 months.
* Eating disorders.
* Consumption of foods fortified with omega-3 fatty acids in the last 3 months.
* Consumption of supplements of omega-3 fatty acids in the last 3 months.
* Participant who have followed either a vegetarian diet for less than six months or an omnivorous diet including fish more than 2 times per week.
Minimum Eligible Age

18 Years

Maximum Eligible Age

45 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

Yes

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Comunidad de Madrid

OTHER

Sponsor Role collaborator

National Research Council, Spain

OTHER_GOV

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

M Pilar Vaquero

Dr

Responsibility Role PRINCIPAL_INVESTIGATOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

M.Pilar Vaquero, Dr

Role: PRINCIPAL_INVESTIGATOR

CSIC

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

M.Pilar Vaquero

Madrid, , Spain

Site Status

Countries

Review the countries where the study has at least one active or historical site.

Spain

References

Explore related publications, articles, or registry entries linked to this study.

Garcia-Maldonado E, Alcorta A, Zapatera B, Vaquero MP. Changes in fatty acid levels after consumption of a novel docosahexaenoic supplement from algae: a crossover randomized controlled trial in omnivorous, lacto-ovo vegetarians and vegans. Eur J Nutr. 2023 Jun;62(4):1691-1705. doi: 10.1007/s00394-022-03050-3. Epub 2022 Nov 23.

Reference Type RESULT
PMID: 36418565 (View on PubMed)

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

IND2018/BIO-9554

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.